Ilya

Golovaty

MD

M.Sc.

Education & Training 

• MD, University of Washington, Seattle, WA (2010–2014)
• Internal Medicine Internship & Residency, University of Washington, Seattle, WA (2014–2017)
• Fellowship in Primary Care Research, University of California, San Francisco (2017–2019)
• MAS in Clinical Research, Implementation Science Track, University of California, San Francisco (2017–2019)

Honors

• Seed Grant Award, Office of Research and Development, VA Puget Sound (2023)
• Pilot Junior Investigator Award, Kaiser/Harvard/UCSF Center for Diabetes Translation Research (2018)
• Mack Lipkin Award Finalist, Society of General Medicine (2018, 2019)
• NIH T32 Research Training Grant (2017–2019)

Research Interests

• Implementation of novel anti-obesity medications in primary care
• Deprescribing in primary care
• Evaluating telehealth platforms for diabetes prevention
• Food insecurity and metabolic disease
• Outpatient diagnostic stewardship

Publication Highlights

• Golovaty I, Sharma M, Van Heerden A, van Rooyen H, Baeten JM, Celum C, Barnabas RV. Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa. J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):522-526. doi: 10.1097/QAI.0000000000001713. PMID: 29771779; PMCID: PMC6037552.
• Golovaty I, Tien PC, Price JC, Sheira L, Seligman H, Weiser SD. Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States. J Nutr. 2020 Jan 1;150(1):91-98. doi: 10.1093/jn/nxz212. PMID: 31504710; PMCID: PMC6946902.
• Golovaty I, Wadhwa S, Fisher L, Lobach I, Crowe B, Levi R, Seligman H. Reach, engagement and effectiveness of in-person and online lifestyle change programs to prevent diabetes. BMC Public Health. 2021 Jul 5;21(1):1314. doi: 10.1186/s12889-021-11378-4. PMID: 34225674; PMCID: PMC8256225.
• Golovaty I, Ritchie ND, Tuomilehto J, Mohan V, Ali MK, Gregg EW, Bergman M, Moin T. Two decades of diabetes prevention efforts: A call to innovate and revitalize our approach to lifestyle change. Diabetes Res Clin Pract. 2023 Apr;198:110195. doi: 10.1016/j.diabres.2022.110195. Epub 2022 Dec 5. PMID: 36470316; PMCID: PMC10079599.
• Golovaty I, Tulloch-Palomino L. Evaluating outpatient diagnostic stewardship of comprehensive polymerase chain reaction Clostridioides difficile testing in a regional health system. Antimicrob Steward Healthc Epidemiol. 2023 Sep 5;3(1):e145. doi: 10.1017/ash.2023.426. PMID: 37780683; PMCID: PMC10540176.
• Golovaty I, Hagan S. Direct-to-Consumer Platforms for New Antiobesity Medications - Concerns and Potential Opportunities. N Engl J Med. 2024 Feb 22;390(8):677-680. doi: 10.1056/NEJMp2312816. Epub 2024 Feb 17. PMID: 38375888.